The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk.

[1]  H. AbdElgawad,et al.  Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion , 2023, Molecules.

[2]  Osama A. Mohammed,et al.  Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways. , 2023, Pathology, research and practice.

[3]  A. Hashem,et al.  The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma - A focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[4]  Osama A. Mohammed,et al.  miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance. , 2023, Pathology, research and practice.

[5]  Gihan F. Asaad,et al.  Chitosan coated clove oil-based nanoemulsion: an attractive option for oral delivery of leflunomide in rheumatoid arthritis. , 2023, International journal of pharmaceutics.

[6]  S. Darwish,et al.  The potential role of miRNAs in the pathogenesis of gallbladder cancer - A focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[7]  Y. Moustafa,et al.  miRNAs orchestration of adrenocortical carcinoma - Particular emphasis on diagnosis, progression and drug resistance. , 2023, Pathology, research and practice.

[8]  T. Usui,et al.  Comparison of Bovine- and Porcine-Derived Decellularized Biomaterials: Promising Platforms for Tissue Engineering Applications , 2023, Pharmaceutics.

[9]  Osama A. Mohammed,et al.  miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma. , 2023, Pathology, research and practice.

[10]  N. S. Ismail,et al.  Development of pyrolo[2,3-c]pyrazole, pyrolo[2,3-d]pyrimidine and their bioisosteres as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological evaluation and molecular dynamics investigations. , 2023, Bioorganic chemistry.

[11]  N. A. El-Boghdady,et al.  The lncRNAs UCA1 and CRNDE target miR-145/TLR4/NF-қB/TNF-α axis in acetic acid-induced ulcerative colitis model: The beneficial role of 3,3-Diindolylmethane. , 2023, International immunopharmacology.

[12]  Kawkab A. Ahmed,et al.  Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis , 2023, Journal of Zhejiang University-SCIENCE B.

[13]  H. M. El-Husseiny,et al.  Stimuli-responsive hydrogels: smart state of-the-art platforms for cardiac tissue engineering , 2023, Frontiers in Bioengineering and Biotechnology.

[14]  Osama A. Mohammed,et al.  The potential role of miRNAs in the pathogenesis of cardiovascular diseases - A focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[15]  Heba Moustafa,et al.  miRNAs orchestration of testicular germ cell tumors - Particular emphasis on diagnosis, progression and drug resistance. , 2023, Pathology, research and practice.

[16]  Osama A. Mohammed,et al.  miRNAs orchestration of cardiovascular diseases - Particular emphasis on diagnosis, and progression. , 2023, Pathology, research and practice.

[17]  Heba Moustafa,et al.  The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A Focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[18]  A. Abulsoud,et al.  miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance. , 2023, Pathology, research and practice.

[19]  A. Abulsoud,et al.  The potential role of miRNAs in the pathogenesis of salivary gland cancer - A Focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[20]  N. Hamdy,et al.  LncRNA NNT-AS1/hsa-miR-485-5p/HSP90 axis in-silico and clinical prospect correlated-to histologic grades-based CRC stratification: A step toward ncRNA Precision. , 2023, Pathology, research and practice.

[21]  Osama A. Mohammed,et al.  miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses. , 2023, Pathology, research and practice.

[22]  Kawkab A. Ahmed,et al.  Implication of Wnt/GSK-3β/β-Catenin Signaling in the Pathogenesis of Mood Disturbances Associated with Hyperthyroidism in Rats: Potential Therapeutic Effect of Naringin. , 2023, ACS chemical neuroscience.

[23]  Ahmed E. Elesawy,et al.  Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications. , 2023, Pathology, research and practice.

[24]  A. Abulsoud,et al.  The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. , 2023, Pathology, research and practice.

[25]  A. Abulsoud,et al.  miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay. , 2023, Pathology, research and practice.

[26]  M. Elshafey,et al.  miR-509-5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11. , 2023, Pathology, research and practice.

[27]  Sherine M Rizk,et al.  Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review. , 2023, Pathology, research and practice.

[28]  A. Abulsoud,et al.  The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer. , 2023, Pathology, research and practice.

[29]  N. Mesbah,et al.  The long non-coding RNA ZFAS1 promotes colorectal cancer progression via miR200b/ZEB1 axis. , 2023, Pathology, research and practice.

[30]  H. M. El-Husseiny,et al.  Impact of the mother's gut microbiota on infant microbiome and brain development , 2023, Neuroscience & Biobehavioral Reviews.

[31]  Amr M. Yehia,et al.  A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. , 2023, Pathology, research and practice.

[32]  Nada Amer,et al.  miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses. , 2023, Pathology, research and practice.

[33]  A. Abulsoud,et al.  The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy. , 2023, Pathology, research and practice.

[34]  Ahmed E. Elesawy,et al.  miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses. , 2023, Pathology, research and practice.

[35]  Ahmed E. Elesawy,et al.  An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. , 2023, Life sciences.

[36]  M. Kaneda,et al.  Impact of Adipose Tissue Depot Harvesting Site on the Multilineage Induction Capacity of Male Rat Adipose-Derived Mesenchymal Stem Cells: An In Vitro Study , 2023, International journal of molecular sciences.

[37]  Osama A. Mohammed,et al.  Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats. , 2023, Life sciences.

[38]  A. Mohamadin,et al.  miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses. , 2023, Pathology, research and practice.

[39]  Abdallah Mansour,et al.  Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. , 2023, Pathology, research and practice.

[40]  O. Shaker,et al.  MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights. , 2023, ACS chemical neuroscience.

[41]  Gamil M. Abd-Allah,et al.  miRNAs as potential game-changers in melanoma: A comprehensive review. , 2023, Pathology, research and practice.

[42]  Mohammed H Rashed,et al.  The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways. , 2023, Pathology, research and practice.

[43]  J. Marchal,et al.  Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. , 2023, Advances in colloid and interface science.

[44]  Sherine M Rizk,et al.  Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of β-catenin protein level. , 2023, Non-coding RNA research.

[45]  Heba Moustafa,et al.  miRNAs role in cervical cancer pathogenesis and targeted therapy: Signaling pathways interplay. , 2023, Pathology, research and practice.

[46]  Ahmed E. Elesawy,et al.  The role of miRNAs in liver diseases: Potential therapeutic and clinical applications. , 2023, Pathology, research and practice.

[47]  A. Abulsoud,et al.  miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance- An emphasis on the interaction of signaling pathways. , 2023, Pathology, research and practice.

[48]  M. Schroff,et al.  Cavrotolimod, a Nanoparticle Toll-like Receptor 9 Agonist, Inhibits Tumor Growth and Alters Immune Cell Composition in Mouse Models of Skin Cancer , 2023, ACS Applied Nano Materials.

[49]  Amr M. Yehia,et al.  Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways. , 2023, Pathology, research and practice.

[50]  A. El-Husseiny,et al.  miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. , 2023, Pathology, research and practice.

[51]  Sylvia F. Fawzi,et al.  The role of miRNAs in insulin resistance and diabetic macrovascular complications - A review. , 2023, International journal of biological macromolecules.

[52]  D. Schrama,et al.  Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma , 2023, Cancers.

[53]  Kawkab A. Ahmed,et al.  The neuroprotective effect of pterostilbene on oxaliplatin-induced peripheral neuropathy via its anti-inflammatory, anti-oxidative and anti-apoptotic effects: Comparative study with celecoxib. , 2023, Life sciences.

[54]  M. Elkady,et al.  miRNAs as cornerstones in adipogenesis and obesity. , 2023, Life sciences.

[55]  Xiaohui Lin,et al.  Defining disease-related modules based on weighted miRNA synergistic network , 2023, Comput. Biol. Medicine.

[56]  M. Tognon,et al.  MicroRNA dysregulations in Merkel cell carcinoma: Molecular mechanisms and clinical applications , 2022, Journal of medical virology.

[57]  M. Eldeib,et al.  miRNAs as cornerstones in diabetic microvascular complications. , 2022, Molecular genetics and metabolism.

[58]  H. M. El-Husseiny,et al.  miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers. , 2022, Life sciences.

[59]  Ahmed Elshafei,et al.  The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke , 2022, Future science OA.

[60]  A. F. A. Samad,et al.  Innovative approaches in transforming microRNAs into therapeutic tools , 2022, Wiley interdisciplinary reviews. RNA.

[61]  D. Weissman,et al.  Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity , 2022, International journal of molecular sciences.

[62]  M. Abdel-Daim,et al.  Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions , 2022, Biomedicine & Pharmacotherapy.

[63]  P. Sabbagh,et al.  The role of altered microRNA expression in premalignant and malignant head and neck lesions with epithelial origin , 2022, Health science reports.

[64]  Mohamed M. Amin,et al.  Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant/type 2 diabetic rat model , 2022, Journal of Drug Delivery Science and Technology.

[65]  L. Rashed,et al.  Association of miRNA-499 rs3746444 A>G genotype variants with type 2 diabetes mellitus and its coronary heart disease complication in adult Egyptian population , 2022, Gene Reports.

[66]  Ahmed S. Doghish,et al.  The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[67]  M. Sobhy,et al.  Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase. , 2022, Pathology, research and practice.

[68]  Ahmed S. Doghish,et al.  Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review. , 2022, International journal of biological macromolecules.

[69]  Mahmoud Elsabahy,et al.  Ameliorative effect of chitosan nanoparticles against carbon tetrachloride-induced nephrotoxicity in Wistar rats , 2022, Pharmaceutical biology.

[70]  N. Hamdy,et al.  Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association. , 2022, Pathology, research and practice.

[71]  S. Salem,et al.  Nanocomposite based on gold nanoparticles and carboxymethyl cellulose: Synthesis, characterization, antimicrobial, and anticancer activities , 2022, Journal of Drug Delivery Science and Technology.

[72]  T. Al-Warhi,et al.  Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies , 2022, Pharmaceuticals.

[73]  N. Hamdy,et al.  Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond. , 2022, International journal of biological macromolecules.

[74]  S. Salem,et al.  Synthesis of Silver Nanocomposite Based on Carboxymethyl Cellulose: Antibacterial, Antifungal and Anticancer Activities , 2022, Polymers.

[75]  Ahmed S. Doghish,et al.  Megalin, a multi-ligand endocytic receptor, and its participation in renal function and diseases: A review. , 2022, Life sciences.

[76]  F. Ari,et al.  Mitochondrial miRNAs (MitomiRs): Their Potential Roles in Breast and Other Cancers. , 2022, Mitochondrion.

[77]  N. El‐Ashmawy,et al.  Carnosine and crocin ameliorate oxidative stress in rats with rhabdomyolysis-induced acute kidney injury through upregulating HO-1 gene expression , 2022, Food Bioscience.

[78]  Ahmed S. Doghish,et al.  A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay. , 2022, Pathology, research and practice.

[79]  W. Elkhatib,et al.  Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt , 2022, PloS one.

[80]  Walaa A. El-Dakroury,et al.  Design, Characterization and In Vivo Performance of Solid Lipid Nanoparticles (SLNs)-Loaded Mucoadhesive Buccal Tablets for Efficient Delivery of Lornoxicam in Experimental Inflammation. , 2022, International journal of pharmaceutics.

[81]  A. A. Ahmed,et al.  miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. , 2022, International journal of biological macromolecules.

[82]  H. M. El-Husseiny,et al.  Smart/stimuli-responsive hydrogels: State-of-the-art platforms for bone tissue engineering , 2022, Applied Materials Today.

[83]  N. Mesbah,et al.  Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis. , 2022, Life sciences.

[84]  Al-aliaa M. Sallam,et al.  miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. , 2022, Pathology, research and practice.

[85]  C. Qi,et al.  MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[86]  S. Mukherjee,et al.  Merkel cell polyomavirus regulates miR183 cluster and piR62011 in Merkel cell carcinoma , 2022, bioRxiv.

[87]  Gang Yin,et al.  Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities , 2022, Signal Transduction and Targeted Therapy.

[88]  N. Hamdy,et al.  Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players. , 2022, Life sciences.

[89]  K. Nouri,et al.  Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options , 2021, Dermatologic therapy.

[90]  M. M. Khalifa,et al.  New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies , 2021, Journal of enzyme inhibition and medicinal chemistry.

[91]  Aya R. Salman,et al.  The Clinical Value of Circulating MicroRNAs in Acute Ischemic Stroke , 2021, Azhar International Journal of Pharmaceutical and Medical Sciences.

[92]  L. Rashed,et al.  MicroRNA-499 Gene Expression in Egyptian Type 2 Diabetes Mellitus Patients with and without Coronary Heart Disease. , 2021, Azhar International Journal of Pharmaceutical and Medical Sciences.

[93]  A. Ismail,et al.  A review of the biological role of miRNAs in prostate cancer suppression and progression. , 2021, International journal of biological macromolecules.

[94]  A. Giordano,et al.  p53 signaling in cancer progression and therapy , 2021, Cancer cell international.

[95]  E. Radwan,et al.  Olmesartan niosomes ameliorates the Indomethacin-induced gastric ulcer in rats: Insights on MAPK and Nrf2/HO-1 signaling pathway , 2021, Pharmaceutical Research.

[96]  Marwa E Shabana,et al.  Famotidine-loaded Solid Self-nanoemulsifying Drug Delivery System Demonstrates Exceptional Efficiency in Amelioration of Peptic Ulcer. , 2021, International journal of pharmaceutics.

[97]  J. Sunshine,et al.  222 Genetic reprogramming of merkel cell carcinoma and melanoma leads to increased MHC-I expression and antitumor immune activation in vitro and in vivo , 2021, Journal for ImmunoTherapy of Cancer.

[98]  G. Calin,et al.  Classical and noncanonical functions of miRNAs in cancers. , 2021, Trends in genetics : TIG.

[99]  Yu Feng,et al.  Structural basis of microRNA processing by Dicer-like 1 , 2021, Nature Plants.

[100]  P. Queirolo,et al.  Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale? , 2021, Frontiers in Oncology.

[101]  Sherehan M. Ibrahim,et al.  Lutein exerts its cardioprotective effect against the experimental model of isoprenaline‐induced myocardial infarction via MIAT/miR‐200a/Nrf2/TXINP pathway , 2021, Journal of biochemical and molecular toxicology.

[102]  W. E. El Rouby,et al.  Graphene oxide and its nanocomposites with EDTA or chitosan induce apoptosis in MCF-7 human breast cancer , 2021, RSC advances.

[103]  A. Moore,et al.  Role of microRNAs in glioblastoma , 2021, Oncotarget.

[104]  Yue Zhou,et al.  Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry , 2021, Theranostics.

[105]  Mona Keivan,et al.  miRNAs; a novel strategy for the treatment of COVID‐19 , 2021, Cell biology international.

[106]  P. Rutkowski,et al.  Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies , 2021, International journal of molecular sciences.

[107]  W. Elkhatib,et al.  Clinical characteristics of Egyptian male patients with COVID‐19 acute respiratory distress syndrome , 2021, PloS one.

[108]  I. Zalaudek,et al.  Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma , 2021, Current Treatment Options in Oncology.

[109]  M. Elshafey,et al.  MicroRNA-567 inhibits cell proliferation and induces cell apoptosis in A549 NSCLC cells by regulating cyclin-dependent kinase 8 , 2021, Saudi journal of biological sciences.

[110]  A. Amin,et al.  Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients With Metabolic Syndrome. , 2021, Canadian journal of diabetes.

[111]  Saswati Banerjee,et al.  Emerging roles of microRNAs in the regulation of Toll-like receptor (TLR)-signaling. , 2021, Frontiers in bioscience.

[112]  E. M. Gedawy,et al.  Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers , 2021, Journal of enzyme inhibition and medicinal chemistry.

[113]  D. Schadendorf,et al.  Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53 , 2020, Oncogene.

[114]  I. Kholová,et al.  Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications , 2020, Diagnostics.

[115]  Huilin Yang,et al.  Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases , 2020, Cell cycle.

[116]  B. Elsadek,et al.  Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase , 2020, Steroids.

[117]  W. Cho,et al.  Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer , 2020, Therapeutic advances in respiratory disease.

[118]  O. Dereure,et al.  Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma , 2020, Cancers.

[119]  Kou-Juey Wu.  The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness , 2020, Biomedical journal.

[120]  W. Elkhatib,et al.  Effect of scopoletin on phagocytic activity of U937-derived human macrophages: Insights from transcriptomic analysis. , 2020, Genomics.

[121]  Jing Wang,et al.  Loss of p53 drives neuron reprogramming in head and neck cancer , 2020, Nature.

[122]  A. Alzahrani.  PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. , 2019, Seminars in cancer biology.

[123]  R. Cui,et al.  Circulating MicroRNAs in Cancer: Potential and Challenge , 2019, Front. Genet..

[124]  C. Larsson,et al.  Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes , 2019, International journal of cancer.

[125]  S. Haan,et al.  Hypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells , 2019, Cells.

[126]  K. Tsai,et al.  Molecular and immune targets for Merkel cell carcinoma therapy and prevention , 2019, Molecular carcinogenesis.

[127]  O. Mansour,et al.  Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients , 2019, Diabetes, metabolic syndrome and obesity : targets and therapy.

[128]  G. Fabbrocini,et al.  Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies , 2019, Dermatology and Therapy.

[129]  J. Hanrahan,et al.  The Role of KRAS in Endometrial Cancer: A Mini-Review , 2019, AntiCancer Research.

[130]  A. Fawzy,et al.  Diagnostic Significance of miR-639 and miR-10b in Βreast Cancer Patients , 2019, Meta Gene.

[131]  R. Rosell,et al.  A novel miR-205-mediated ERRFI1/EGFR regulatory pathway in MET-addicted cancer cells: emerging biomarkers for secondary resistance , 2018 .

[132]  I. Ulitsky,et al.  Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features , 2018, Proceedings of the National Academy of Sciences.

[133]  M. Abdel-Hamid,et al.  Association of MicroRNA related single nucleotide polymorphisms 196A-2 and 499 with the risk of hepatocellular carcinoma in Egyptian patients , 2018, Meta Gene.

[134]  S. Yom,et al.  Merkel cell carcinoma: An update and review: Current and future therapy. , 2017, Journal of the American Academy of Dermatology.

[135]  J. Becker,et al.  Merkel cell carcinoma , 2017, Nature Reviews Disease Primers.

[136]  G. Dotto,et al.  The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. , 2017, Cell reports.

[137]  Ahmed S. Doghish,et al.  Matrix metalloproteinase (MMP)-2 -1306 C > T gene polymorphism affects circulating levels of MMP-2 in Egyptian asthmatic patients , 2016 .

[138]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[139]  Kristina Stumpf,et al.  Tumor-associated stromal cells as key contributors to the tumor microenvironment , 2016, Breast Cancer Research.

[140]  I. Tannock,et al.  Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors , 2016, Neoplasia.

[141]  B. Nielsen,et al.  Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates , 2016, Molecular therapy. Nucleic acids.

[142]  Genichiro Ishii,et al.  Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. , 2016, Advanced drug delivery reviews.

[143]  H. Feilotter,et al.  Roles for miR-375 in Neuroendocrine Differentiation and Tumor Suppression via Notch Pathway Suppression in Merkel Cell Carcinoma. , 2016, The American journal of pathology.

[144]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[145]  Bader Al-Shammari,et al.  A Mechanistic Study on the Amiodarone-Induced Pulmonary Toxicity , 2016, Oxidative medicine and cellular longevity.

[146]  Dong Eun Kim,et al.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation , 2015, Nature Cell Biology.

[147]  D. Pardoll,et al.  STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade , 2015, Science Translational Medicine.

[148]  S. Knuutila,et al.  miRNA-34a underexpressed in Merkel cell polyomavirus-negative Merkel cell carcinoma , 2015, Virchows Archiv.

[149]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[150]  C. Porta,et al.  Targeting PI3K/Akt/mTOR Signaling in Cancer , 2014, Front. Oncol..

[151]  Annette S. Kim,et al.  Characterization of the Merkel Cell Carcinoma miRNome , 2014, Journal of skin cancer.

[152]  K. Riabowol,et al.  Survivin as a Preferential Target for Cancer Therapy , 2014, International journal of molecular sciences.

[153]  P. Sharp,et al.  The role of miRNAs in regulating gene expression networks. , 2013, Journal of molecular biology.

[154]  A. Griveau,et al.  Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death. , 2013, International journal of pharmaceutics.

[155]  C. Larsson,et al.  MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma , 2013, The Journal of investigative dermatology.

[156]  M. Stern,et al.  MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor , 2013, Oncogene.

[157]  J. Distler,et al.  Autophagy: a key pathway of TNF-induced inflammatory bone loss. , 2013, Autophagy.

[158]  M. Negrini,et al.  Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence , 2012, Clinical Cancer Research.

[159]  A. Tsung,et al.  miR-375 inhibits autophagy and reduces viability of hepatocellular carcinoma cells under hypoxic conditions. , 2012, Gastroenterology.

[160]  A. Dömling,et al.  Survivin Is a Therapeutic Target in Merkel Cell Carcinoma , 2012, Science Translational Medicine.

[161]  E. White.  Role of autophagy in cancer , 2012 .

[162]  Margaret S. Ebert,et al.  Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.

[163]  A. Bader,et al.  Developing therapeutic microRNAs for cancer , 2011, Gene Therapy.

[164]  Tomohiro Miyoshi,et al.  Many ways to generate microRNA-like small RNAs: non-canonical pathways for microRNA production , 2010, Molecular Genetics and Genomics.

[165]  S. Hammond,et al.  Emerging paradigms of regulated microRNA processing. , 2010, Genes & development.

[166]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[167]  Xiuping Liu,et al.  Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells , 2009, Autophagy.

[168]  M. Yamakuchi,et al.  MiR-34, SIRT1, and p53: The feedback loop , 2009, Cell cycle.

[169]  Mauro Biffoni,et al.  The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.

[170]  Robert Blelloch,et al.  Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. , 2008, Genes & development.

[171]  S. Kauppinen,et al.  LNA-mediated microRNA silencing in non-human primates , 2008, Nature.

[172]  H. Hermeking.  p53 enters the microRNA world. , 2007, Cancer cell.

[173]  Gregory J. Hannon,et al.  microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.

[174]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[175]  M. Todesco,et al.  Target mimicry provides a new mechanism for regulation of microRNA activity , 2007, Nature Genetics.

[176]  D. Bartel,et al.  Intronic microRNA precursors that bypass Drosha processing , 2007, Nature.

[177]  Wenbin Ye,et al.  MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.

[178]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[179]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[180]  G. Hannon,et al.  Processing of primary microRNAs by the Microprocessor complex , 2004, Nature.

[181]  Phillip D Zamore,et al.  Sequence-Specific Inhibition of Small RNA Function , 2004, PLoS biology.

[182]  K. Hussain,et al.  Merkel cell carcinoma , 2001, Clinical and experimental dermatology.

[183]  N. El-Deeb,et al.  New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story , 2023, Journal of Molecular Structure.

[184]  Atef A Bassyouni,et al.  Plasma endoglin in Type2 diabetic patients with nephropathy. , 2019, Diabetes & metabolic syndrome.

[185]  D. Schadendorf,et al.  Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs. , 2017, European journal of cancer.

[186]  S. Ray,et al.  Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. , 2015, Advanced drug delivery reviews.

[187]  Zhiguo Wang,et al.  The principles of MiRNA-masking antisense oligonucleotides technology. , 2011, Methods in molecular biology.

[188]  H. Grosshans.  Regulation of microRNAs , 2010 .